Member Info for gixer

Sphinx, the new function claim was only submitted on the 29th of August (one month ago) once SAMR finally officially released the "Implementation Rules for New Functions and Product Technology Evaluation of Health Foods" on 28th August.

The Technical Specifications for Testing and Evaluation of Health Food (2003 Version) was abolished in July 2018 so we can hardly blame PXS or By-Health for the delay. The good thing was By-Health were ready and waiting.

Although there is no requirement to publish them I hope we get some (unofficial) figures for March to September.

What test results are we waiting on?

A bit of positivity in the results would go down a treat :)

Find out soon.

"The number of cardiovascular patients in my country has reached 330 million. These people should pay attention!"

"As the first company to apply for new functions, behind the approval document are countless sweats and sleepless nights by the By-Health R&D team."

https://www-163-com.translate.goog/dy/article/IFAPNQ6G05534E2F.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

"The cardiovascular and cerebrovascular health market has an even higher year-on-year growth rate, hitting a high growth rate of 91% in Q1 of 2023."

"The growth rate of cross-border channels in the cardiovascular and cerebrovascular health market is even stronger, hitting a high growth rate of 97% in Q1 of 2023."

"Tomatoes received widespread attention as a nutrient-rich food at the recent Health and Nutrition Congress academic session."

"Water-soluble tomato concentrate, a tomato essence obtained through special processing, was also mentioned at the meeting. It is more easily absorbed by the body than regular tomatoes and has no risk of bleeding. "

https://zhuanlan-zhihu-com.translate.goog/p/657827019?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

Would be nice to get the results on Monday morning but my guess is Friday.

As the date on the video says "Sep 21, 2023" I assume that its new.

Note that it also mentions the Gut-Heart Axis.

http://postimg.cc/23d96pCY

Https://www.youtube.com/watch?v=r_UUKlww6N4

Don't forget By-Health is also a distributor for Fruitflow and might have already been selling it to other businesses.

Yes alfista, from the recent RNS we all know that......

"On 29 August 2023 it was announced in China that BYHEALTH had submitted: i) the first application under the Implementation Rules, seeking to obtain a new permitted health function claim for foods such as Fruitflow which help to 'maintain normal platelet aggregation function and benefit blood flow health'; and ii) some related product registration applications."

How many products they have registered (for Blue Cap) remains an unknown but I am sure B-H will require a sizable amount of FF for any product(s) launch.

Yep, firm news on revenue that will take us into profit.

Https://www-prnasia-com.translate.goog/story/418933-1.shtml?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

PR Newswire

BY-HEALTH hosted a sub-forum at the Asian Nutrition Conference to convey the innovative trends in the dietary supplement industry

Professor Yang Yan of Sun Yat-sen University shared the clinical research results of water-soluble tomato concentrate, Qingluoxin, in maintaining normal platelet aggregation function. In the report, she introduced in detail the impact of platelet aggregation on cardiovascular health problems, as well as the randomized, double-blind, crossover design. In clinical studies, it was observed that Qingluoxin intervention significantly inhibited platelet excessive activation and aggregation, showing a positive impact on platelet function in middle-aged and elderly people.

I think the AGM date is normally released with the results.

Sorry wrong board and no idea what happened ????

I think the AGM date is normally released with the results.

I think its another great and significant bit of news on the benefits of Fruitflow.

Roll on the human trials. Although these could take a long time.

"thoughts"

Yes it would be good if Provexis had applied for this patent but By-Health have put in the work and paid for it. Provexis cant patent FF for every scenario.

"Who would benefit"

Well you can only assume By-Health for holding the patent and Provexis for supplying the FF.

It does. 👍

"Specifically, the oral or injectable administration forms of the above composition for treating cerebral ischemia-reperfusion injury include solutions, powders, tablets, granules, capsules, emulsions and suspensions. It will be appreciated that the above-described compositions for treating cerebral ischemia-reperfusion injury may be administered by subcutaneous injection, intra-cerebral administration, intravenous injection, oral administration, or the like."

"In a specific example, the dosage of the water-soluble tomato concentrate in the composition for treating cerebral ischemia-reperfusion injury is 15mg/kg to 150mg/kg. Alternatively, the dose of water-soluble tomato concentrate in the composition for treating cerebral ischemia-reperfusion injury is 47.25mg/kg. It will be appreciated that the specific concentration may be adjusted as desired depending on the condition or individual situation."

Use of water-soluble tomato concentrate in preparation of composition for treating cerebral ischemia-reperfusion injury

https://patents.google.com/patent/CN116688025A/en?q=(%22water-soluble+tomato%22)&oq=%22water-soluble+tomato%22&sort=new

"Based on this, the application provides a new use of a water-soluble tomato concentrate, relating to the use of a water-soluble tomato concentrate in the preparation of a composition for preventing, alleviating or treating cerebral ischemia-reperfusion injury."

"Abstract

The present application relates to the use of a water-soluble tomato concentrate for the preparation of a composition for the treatment of cerebral ischemia-reperfusion injury. Through long-term research, researchers of the application firstly find and prove that the water-soluble tomato concentrate has obvious repairing effect on ischemic cerebral apoplexy reperfusion injury according to nerve function evaluation, tetrazolium red staining and HE staining, can obviously reduce cerebral infarction area, reduce nerve function score and improve brain tissue pathology, and can be applied to preparing a composition for treating cerebral ischemia-reperfusion injury."

:-)